Jun Ohsumi

1.4k total citations
31 papers, 1.2k citations indexed

About

Jun Ohsumi is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Jun Ohsumi has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Surgery. Recurrent topics in Jun Ohsumi's work include Peroxisome Proliferator-Activated Receptors (14 papers), Metabolism, Diabetes, and Cancer (14 papers) and Adipose Tissue and Metabolism (4 papers). Jun Ohsumi is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (14 papers), Metabolism, Diabetes, and Cancer (14 papers) and Adipose Tissue and Metabolism (4 papers). Jun Ohsumi collaborates with scholars based in Japan, Germany and United States. Jun Ohsumi's co-authors include Sachiko Sakakibara, Kenji Miyadai, Junko Yamaguchi, Shu Takahashi, Yo Takiguchi, Noriaki Kume, Manabu Minami, Toru Kita, Takashi Nakayama and Kazutaka Hayashida and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Analytical Chemistry.

In The Last Decade

Jun Ohsumi

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Ohsumi Japan 18 535 386 311 180 151 31 1.2k
Yoko Yamagiwa Japan 17 404 0.8× 222 0.6× 214 0.7× 108 0.6× 239 1.6× 38 1.0k
Kojiro Matsumoto Japan 27 1.3k 2.4× 641 1.7× 139 0.4× 448 2.5× 129 0.9× 81 2.1k
Matthew G.K. Benesch Canada 24 1.2k 2.2× 172 0.4× 218 0.7× 219 1.2× 148 1.0× 63 1.6k
Toshifumi Ito Japan 18 653 1.2× 159 0.4× 280 0.9× 168 0.9× 339 2.2× 44 1.2k
Xianping Lu China 21 1.2k 2.2× 205 0.5× 505 1.6× 86 0.5× 79 0.5× 44 1.7k
Eric Hampton United States 13 625 1.2× 277 0.7× 752 2.4× 100 0.6× 444 2.9× 17 1.5k
Joanne R. Brown United Kingdom 11 459 0.9× 286 0.7× 339 1.1× 58 0.3× 114 0.8× 13 1.3k
Aintzane Asumendi Spain 22 723 1.4× 346 0.9× 259 0.8× 112 0.6× 52 0.3× 47 1.2k
Jenai M. Kailey United States 13 654 1.2× 380 1.0× 303 1.0× 59 0.3× 109 0.7× 15 1.3k
R E Law United States 15 843 1.6× 220 0.6× 177 0.6× 112 0.6× 171 1.1× 20 1.4k

Countries citing papers authored by Jun Ohsumi

Since Specialization
Citations

This map shows the geographic impact of Jun Ohsumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ohsumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ohsumi more than expected).

Fields of papers citing papers by Jun Ohsumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ohsumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ohsumi. The network helps show where Jun Ohsumi may publish in the future.

Co-authorship network of co-authors of Jun Ohsumi

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ohsumi. A scholar is included among the top collaborators of Jun Ohsumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ohsumi. Jun Ohsumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujii, Kunihiko, Kousei Shimada, Yoshiyuki Onishi, et al.. (2018). Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization. Bioorganic & Medicinal Chemistry. 26(18). 5099–5117. 7 indexed citations
2.
Fujii, Kunihiko, Kousei Shimada, Yoshiyuki Onishi, et al.. (2018). Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification. Bioorganic & Medicinal Chemistry. 26(18). 5079–5098. 11 indexed citations
3.
Furukawa, Akihiro, Tsuyoshi Arita, Takehiro Fukuzaki, et al.. (2012). Synthesis and biological evaluation of novel (−)-cercosporamide derivatives as potent selective PPARγ modulators. European Journal of Medicinal Chemistry. 54. 522–533. 13 indexed citations
4.
Furukawa, Akihiro, Tsuyoshi Arita, Takehiro Fukuzaki, et al.. (2011). Substituents at the naphthalene C3 position of (−)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARγ partial agonists. Bioorganic & Medicinal Chemistry Letters. 22(3). 1348–1351. 16 indexed citations
5.
Uto, Yoshikazu, Yuko Ueno, Yohei Kiyotsuka, et al.. (2011). Discovery of novel SCD1 inhibitors: 5-Alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine] analogs. European Journal of Medicinal Chemistry. 46(5). 1892–1896. 18 indexed citations
6.
Furukawa, Akihiro, Tsuyoshi Arita, Susumu Satoh, et al.. (2010). Discovery of a novel selective PPARγ modulator from (−)-Cercosporamide derivatives. Bioorganic & Medicinal Chemistry Letters. 20(7). 2095–2098. 16 indexed citations
7.
Uto, Yoshikazu, Yuko Ueno, Yohei Kiyotsuka, et al.. (2010). Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4′-piperidine] analogs. European Journal of Medicinal Chemistry. 45(11). 4788–4796. 27 indexed citations
9.
10.
Furukawa, Akihiro, Tsuyoshi Arita, Susumu Satoh, et al.. (2008). (−)-Cercosporamide derivatives as novel antihyperglycemic agents. Bioorganic & Medicinal Chemistry Letters. 19(3). 724–726. 8 indexed citations
11.
Okuno, Akira, et al.. (2008). CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats. European Journal of Pharmacology. 601(1-3). 192–197. 18 indexed citations
12.
Okuyama, Ryo, Toshihiko Fujiwara, & Jun Ohsumi. (2003). High glucose potentiates palmitate‐induced NO‐mediated cytotoxicity through generation of superoxide in clonal β‐cell HIT‐T15. FEBS Letters. 545(2-3). 219–223. 18 indexed citations
13.
Shimaoka, Takeshi, Takashi Nakayama, Noriaki Kume, et al.. (2003). Cutting Edge: SR-PSOX/CXC Chemokine Ligand 16 Mediates Bacterial Phagocytosis by APCs Through its Chemokine Domain. The Journal of Immunology. 171(4). 1647–1651. 133 indexed citations
14.
Takayama, Tomoko, Hiroyuki Hanzawa, Kimihisa Ichikawa, et al.. (2002). Crystal Structure of the Antigen-Binding Fragment of Apoptosis-Inducing Mouse Anti-Human Fas Monoclonal Antibody HFE7A. The Journal of Biochemistry. 131(1). 137–143. 5 indexed citations
15.
Tobe, Kazuyuki, Ryo Suzuki, Masashi Aoyama, et al.. (2001). Increased Expression of the Sterol Regulatory Element-binding Protein-1 Gene in Insulin Receptor Substrate-2−/−Mouse Liver. Journal of Biological Chemistry. 276(42). 38337–38340. 110 indexed citations
16.
Ichikawa, Kimihisa, Junko Yamaguchi, Kenji Watanabe, et al.. (2000). Cloning and Expression of a Novel Murine Anti-human Fas Antibody. Bioscience Biotechnology and Biochemistry. 64(9). 1903–1908. 3 indexed citations
17.
Ichikawa, Kimihisa, Masahiko Ohtsuki, Jun Ohsumi, et al.. (2000). A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity. International Immunology. 12(4). 555–562. 46 indexed citations
18.
Miyadai, Kenji, et al.. (1996). Importance of the Carboxy-terminus of Human Interleukin-11 in Conserving Its Biological Activity. Bioscience Biotechnology and Biochemistry. 60(3). 541–542. 1 indexed citations
19.
Kawashima, Ichiro, et al.. (1991). Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin‐11. FEBS Letters. 283(2). 199–202. 128 indexed citations
20.
Ohsumi, Jun, et al.. (1991). Adipogenesis inhibitory factor A novel inhibitory regulator of adipose conversion in bone marrow. FEBS Letters. 288(1-2). 13–16. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026